Jade PTA Balloon Dilatation Catheter 596024032Recalls & reported problems
OrbusNeich Medical (ShenZhen) Co., Ltd. · Percutaneous Transluminal Angioplasty (PTA) Catheter · Class 2
All models of Jade PTA Balloon Dilatation Catheter (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 06934955904936), received between Apr 25, 2024 and May 13, 2024 — classified as 2 injuries.
The most frequently reported specific device problem is “Material Separation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Separation1
- Material Split, Cut or Torn1
Patient problems
- Foreign Body In Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 13, 2024Material Separation; Material Separation
THE JADE OTW .018" 200CM (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) PTA BALLOON WAS USED FOR TREATMENT OF 99% STENOSED, HEAVILY CALCIFIED, IN-STENT RESTENOSIS (ISR) LESION IN SUPERFICIAL FEMORAL ARTERY (SFA) VIA RADIAL ACCESS 6FR GUIDING SHEATH WAS IN USE. THE NON-CSI/NON-ABBOTT ATHERECTOMY CATHETER HAD DIFFICULTY TRACKING ON THE VIPERWIRE ADVANCE GUIDE WIRE WITH FLEX TIP BUT ATHERECTOMY WAS ABLE TO BE PERFORMED ON THE ISR LESION. THERE WAS NO ALLEGATION OF MALFUNCTION AGAINST THE VIPERWIRE. THE VIPERWIRE AND NON-CSI/NON-ABBOTT ATHERECTOMY CATHETER WERE REMOVED. THE JADE OTW BALLOON WAS ADVANCED OVER THE NON-CSI/NON- ABBOTT WORKHORSE FRONTLINE GUIDE WIRE INTO THE ISR AND INFLATED AT SIXTEEN ATMOSPHERES (ATM). THE NOMINAL PRESSURE IS FOURTEEN ATM AND THE BURSTING PRESSURE IS EIGHTEEN ATM. DURING INFLATION, THE PATIENT BENT THEIR LEG THAT WAS BEING TREATED. THE BALLOON BURST. THE BURST BALLOON HAD THREE COMPONENTS. THE MAJOR PART WAS ATTACHED TO THE CATHETER AND WAS REMOVED ALONG WITH THE SECOND PART. CINE ANGIOGRAPHIC IMAGING AND FLUOROSCOPY REVEALED THE THIRD COMPONENT REMAINED IN THE RIGHT BRACHIAL ARTERY. MECHANICAL ASPIRATION WAS ATTEMPTED VIA RADIAL ACCESS TO SNARE THE FRACTURED C
Patient problems: Foreign Body In Patient
MAUDE report 19299306 ↗InjuryApr 25, 2024Material Split, Cut or Torn; Material Split, Cut or Torn
THE JADE OTW .018" 200CM PTA BALLOON WAS USED FOR TREATMENT OF 99% STENOSED, HEAVILY CALCIFIED, IN-STENT RESTENOSIS (ISR) LESION IN SUPERFICIAL FEMORAL ARTERY (SFA) VIA RADIAL ACCESS. 6FR TERUMO GUIDING SHEATH WAS IN USE. THE NON-CSI/NON-ABBOTT ATHERECTOMY CATHETER (AURYON) HAD DIFFICULTY TRACKING ON THE VIPERWIRE ADVANCE GUIDE WIRE WITH FLEX TIP BUT ATHERECTOMY WAS ABLE TO BE PERFORMED ON THE ISR LESION. THERE WAS NO ALLEGATION OF MALFUNCTION AGAINST THE VIPERWIRE. THE VIPERWIRE AND NON-CSI/NON-ABBOTT ATHERECTOMY CATHETER WERE REMOVED. THE JADE OTW BALLOON WAS ADVANCED OVER THE ASAHI MINAMO WORKHORSE FRONTLINE GUIDE WIRE INTO THE ISR AND INFLATED AT SIXTEEN ATMOSPHERES (ATM). THE NOMINAL PRESSURE IS FOURTEEN ATM AND THE BURSTING PRESSURE IS EIGHTEEN ATM. DURING INFLATION, THE PATIENT BENT HIS LEG THAT WAS BEING TREATED. THE BALLOON BURST. THE BURST BALLOON HAD THREE COMPONENTS. THE MAJOR PART WAS ATTACHED TO THE CATHETER AND WAS REMOVED ALONG WITH THE SECOND PART. CINE ANGIOGRAPHIC IMAGING AND FLUOROSCOPY REVEALED THE THIRD COMPONENT REMAINED IN THE RIGHT BRACHIAL ARTERY. MECHANICAL ASPIRATION WAS ATTEMPTED VIA RADIAL ACCESS TO SNARE THE FRACTURED COMPONENT BUT FAILED. MECHANICAL
Patient problems: Foreign Body In Patient
MAUDE report 19178419 ↗
Other Catheter, Angioplasty, Peripheral, Transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page